Form 4: Guardant Health Executive Darya Chudova Reports Stock Transactions
SEC Form 4 Filing
Darya Chudova, Chief Technology Officer of Guardant Health, reports the acquisition and disposal of common stock related to performance-based restricted stock units.
Summary
- On February 1, 2025, Darya Chudova, Chief Technology Officer of Guardant Health, Inc., reported transactions involving the company's common stock.
- These transactions included the acquisition of 21,863 shares upon the vesting of performance-based restricted stock units.
- Simultaneously, 8,352 shares were disposed of at a price of $46.98 to cover tax withholding obligations.
- Following these transactions, Chudova directly owns 70,064 shares of Guardant Health common stock.
Sentiment
Score: 5
Explanation: The document is a routine regulatory filing detailing stock transactions by a company executive. It doesn't inherently convey positive or negative sentiment.
Industry Context
Form 4 filings are standard practice for company insiders to report transactions in their company's stock, ensuring transparency and compliance with SEC regulations.
Stakeholder Impact
- The transactions may have a minor impact on shareholders due to the change in ownership by a key executive, but the overall effect is likely minimal.
Key Dates
| Date | Description |
|---|---|
| 02/01/2025 | Date of earliest transaction (acquisition and disposal of shares). |
| 02/01/2025 | Date performance-based restricted stock units were exercised. |
| 02/03/2025 | Date of signature for the Form 4 filing. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.